Next generation ReSTOR
Alcon has launched the +3.0 Add Power AcrySof ReSTOR aspheric intraocular lens (IOL) with natural chromophore. The lens gained its CE mark in late 2007 and has been available throughout the EU since mid-September 2008.
Alcon has launched the +3.0 Add Power AcrySof ReSTOR aspheric intraocular lens (IOL) with natural chromophore. The lens gained its CE mark in late 2007 and has been available throughout the EU since mid-September 2008.
The +3.0 Add Power IOL, a refinement of the +4.0 Add Power lens model, can be inserted through a 2.2 mm incision, and is implanted in exactly the same manner as the +4.0 add lens, eradicating the learning curve.
The lens has been associated with a similar incidence and degree of adverse events as the earlier model, and has a high rate of patient satisfaction. The rate of success is also high: at three months, 94.9% of patients had best corrected visual acuities (near, intermediate and distance combined) of ≥20/40.
To read OTE's full news coverage of the XXVI congress of the European Society of Cataract & Refractive Surgery, please click here.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Evaluating the clinical performance of ZEISS AT ELANA and the new ’ELISA’* approach
August 5th 2025In this insightful analysis, Dr. Joong Hun Kim presents real-world clinical outcomes with bilateral implantation of ZEISS AT ELANA 841P. Dr. Kim recommends AT ELANA® 841P as an excellent option for patients undergoing cataract surgery as its fully trifocal optical design translates into a full range of vision. He also introduces the so-called ‘ELISA’ approach for patients requiring astigmatic correction in one eye only, combining AT ELANA 841P and ZEISS AT LISA tri toric 939MP. Early objective and subjective clinical data from this novel approach reveal promising visual outcomes and high patient satisfaction
